The first edition of the Difco™ & BBL™ Manual marks the beginning of a new tradition. The new manual replaces the Difco Manual (11th edition) and the Manual of BBL Products and Laboratory Procedures (6th edition). The new Difco & BBL Manual is a comprehensive guide to our entire line of Difco and BBL brand media including dehydrated culture media (DCM) and prepared plated, tubed and bottled media.

Highlights of the manual include:

1. PRODUCT DESCRIPTIONS

• Medium formulation
• Recommended quality control organisms and expected results
• Relevant information concerning the history, ingredients and usage of each medium
• BD catalog numbers for all packaging configurations • Icons denoting "official" and "standard methods" publications

2. FLOWCHARTS

• Delineate the recommended media and reagents for identification of food pathogens

3. APPLICATION TABLES

• For both industrial and clinical laboratories

4. CD-ROM of Manual with search feature included
In addition, over 400 color photographs (including 50 new photographs) clearly depict colonial morphology and other pertinent characteristics such as hemolysis and color reactions.

To Order Your Manual:

• Order through Amazon.com or
• Call 888-237-2762 (8:30 am - 5:30 pm)

ORDERING INFORMATION:
Cat. No.: 220225
Quantity: 1
Unit: EA
Description:Difco™ & BBL™ Manual, Manual of Microbiological Culture Media

This press release may contain certain forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future revenues, products and income, or events or developments that BD expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; changes in interest or foreign currency exchange rates; difficulties inherent in product development and delays in product introductions; changes in regional, national or foreign economic conditions; increases in energy costs; fluctuations in costs and availability of raw materials and in BD's ability to maintain favorable supplier arrangements and relationships; and changes in healthcare or other governmental regulation; issuance of new or revised accounting standards, as well as other factors discussed in this press release and in BD's filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by applicable laws or regulations.